Research Directory

Changes in the landscape for genome editing

Read more

ASCO 2024

Read more

More advanced planning needed for antimicrobials

Read more

New antibiotics pass regulatory hurdles

Read more

EU prepares for expansion of biotech

Read more

Long overdue, the EU capital markets plan is revived

Read more

Swiss biotech helped by international deals, drug wins, By Jane Morrison

Read more

GLP-1 agonists shake up the sector

Read more

New oncology drugs in pre-registration, late stage development

Read more

FDA guidance on drugs for early Alzheimer's disease

Read more